Immunogenicity and safety following primary and booster vaccination with a hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated poliovirus and …
NP Klein, R Abu-Elyazeed, B Cheuvart… - Human Vaccines & …, 2019 - Taylor & Francis
Combined hexavalent diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated
poliomyelitis and Haemophilus influenzae type b vaccine (DTaP-HBV-IPV/Hib) can further …
poliomyelitis and Haemophilus influenzae type b vaccine (DTaP-HBV-IPV/Hib) can further …
Comparative effectiveness of acellular versus whole-cell pertussis vaccines in teenagers
NP Klein, J Bartlett, B Fireman, A Rowhani-Rahbar… - …, 2013 - publications.aap.org
BACKGROUND: During the 1990s, the United States switched from combined diphtheria,
tetanus toxoids, whole-cell pertussis (DTwP) vaccines to combined acellular pertussis …
tetanus toxoids, whole-cell pertussis (DTwP) vaccines to combined acellular pertussis …
Immunogenicity and reactogenicity of four doses of diphtheria-tetanus-three-component acellular pertussis-hepatitis B-inactivated polio virus-Haemophilus influenzae …
I Tichmann-Schumann, P Soemantri… - The Pediatric …, 2005 - journals.lww.com
Background: The 7-valent pneumococcal (7vPn) conjugate vaccine is licensed for primary
and booster vaccination according to the same immunization schedules as routinely …
and booster vaccination according to the same immunization schedules as routinely …
Primary course immunogenicity and reactogenicity of a new diphtheria‐tetanus‐whole cell pertussis vaccine (DTPw)
T Nolan, G Hogg, MA DARCY… - Journal of paediatrics …, 1997 - Wiley Online Library
Objective: To establish safety, immunogenicity, and batch stability of a reformulated whole
cell pertussis based diphtheria‐tetanus‐whole cell pertussis (DTP) vaccine (nDTPw) …
cell pertussis based diphtheria‐tetanus‐whole cell pertussis (DTP) vaccine (nDTPw) …
[HTML][HTML] Decennial administration in young adults of a reduced-antigen content diphtheria, tetanus, acellular pertussis vaccine containing two different concentrations …
C Vandermeulen, H Theeten, N Rathi, S Kuriyakose… - Vaccine, 2015 - Elsevier
Background Regular booster vaccination might be necessary throughout life to protect
against pertussis infection. Nevertheless the duration of protection after booster vaccination …
against pertussis infection. Nevertheless the duration of protection after booster vaccination …
Waning immunity after receipt of pertussis, diphtheria, tetanus, and polio-related vaccines: a systematic review and meta-analysis
Pertussis, diphtheria, and tetanus (DTP)–containing vaccines combined with polio vaccines
are recommended by the World Health Organization as part of routine immunization …
are recommended by the World Health Organization as part of routine immunization …
Assessment of safety and efficacy against Bordetella pertussis of a new tetanus-reduced dose diphtheria-acellular pertussis vaccine in a murine model
HJ Kwon, SB Han, BR Kim, KR Kang, DH Huh… - BMC infectious …, 2017 - Springer
Background Tetanus-reduced dose diphtheria-acellular pertussis (Tdap) vaccination during
adolescence was introduced in response to the resurgence of pertussis in various countries …
adolescence was introduced in response to the resurgence of pertussis in various countries …
Comparison of the reactogenicity and immunogenicity of a combined diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated polio (DTPa–HBV–IPV) vaccine …
J Arıstegui, R Dal-Re, J Dıez-Delgado, J Mares… - Vaccine, 2003 - Elsevier
An open, randomised, multicentre trial was performed to compare the reactogenicity and
safety profile of the administration of a hexavalent diphtheria-tetanus-acellular pertussis …
safety profile of the administration of a hexavalent diphtheria-tetanus-acellular pertussis …
Safety, immunogenicity and persistence of immune response to the combined diphtheria, tetanus, acellular pertussis, poliovirus and Haemophilus influenzae type b …
Y Li, RC Li, Q Ye, C Li, YP Liu, X Ma, Y Li… - Human Vaccines & …, 2017 - Taylor & Francis
We conducted 3 phase III, randomized, open-label, clinical trials assessing the safety,
reactogenicity (all studies), immunogenicity (Primary vaccination study) and persistence of …
reactogenicity (all studies), immunogenicity (Primary vaccination study) and persistence of …
Rationale for use of Tdap booster vaccines for adolescent immunization: Overview of efficacy, safety, and clinical use
WP Hitchcock - Clinical pediatrics, 2006 - journals.sagepub.com
Pertussis is one of the only vaccine-preventable diseases with increasing incidence in the
United States. The incidence of pertussis infection in adolescents is a growing concern; it …
United States. The incidence of pertussis infection in adolescents is a growing concern; it …